Database for collecting clinical data on pulmonary hypertension
Database for Clinical and Anamnestic Data in Pulmonary Hypertension
Medical University of Graz · NCT01607502
This study is collecting health information and blood samples from people with pulmonary hypertension to better understand the condition and how to treat it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 900 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of Graz (other) |
| Locations | 1 site (Graz) |
| Trial ID | NCT01607502 on ClinicalTrials.gov |
What this trial studies
This study aims to gather clinical and anamnestic data from patients with pulmonary hypertension (PH) and controls, along with blood samples for a biobank. By systematically collecting data through various invasive and non-invasive methods, including right heart catheterization and echocardiography, the study seeks to enhance the understanding of PH and its different forms. The collected data will help in characterizing patients better and may improve the analysis of disease progression and treatment strategies.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with pulmonary hypertension, those at risk for developing the condition, and individuals exhibiting symptoms potentially related to PH.
Not a fit: Patients who are unable to provide written informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management of pulmonary hypertension through better understanding and characterization of the disease.
How similar studies have performed: While this approach of data collection is common, the specific focus on pulmonary hypertension and the establishment of a comprehensive database may provide novel insights into the condition.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with pulmonary hypertension * patients at risk for getting pulmonary hypertension * patients who have symptoms which my be due to pulmonary hypertension when we have their written informed consent. Exclusion Criteria: * patients without written informed consent
Where this trial is running
Graz
- Medical University of Graz — Graz, Austria (RECRUITING)
Study contacts
- Principal investigator: Horst Olschewski, MD — Medical University of Graz
- Study coordinator: Horst Olschewski, MD
- Email: horst.olschewski@medunigraz.at
- Phone: +43-316-385-12183
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pulmonary Hypertension, Pulmonary hypertension, database, biomarker